DIGITOF
LIVE

Serial Number

79229136

Owner

BiosparQ B.V.

Filing Date

Dec 18, 2017

Add to watchlist:

No watchlists yet
View on USPTO

DIGITOF Trademark

Serial Number: 79229136 • Registration: 5516373

DIGITOF is a trademark filed by BiosparQ B.V. on December 18, 2017. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

BiosparQ B.V. (4 trademarks)

Galileiweg 8

Entity Type: 99

Trademark Details

Filing Date

December 18, 2017

Registration Date

July 17, 2018

Published for Opposition

May 1, 2018

Cancellation Date

January 31, 2025

Goods & Services

Medical services with regard to detecting and diagnosing bacteria in human, veterinary and industrial samples for medical diagnostic purposes in fields that include treatment of infectious diseases, management of disease outbreaks, and treatment of immune system related diseases and disorders; advisory services relating to medical equipment and instruments used for detecting and diagnosing bacteria in human, veterinary and industrial samples for medical diagnostic purposes in fields that include treatment of infectious diseases, management of disease outbreaks, and treatment of immune system related diseases and disorders; rental of medical equipment used for detecting and diagnosing bacteria in human, veterinary and industrial samples for medical diagnostic purposes in fields that include treatment of infectious diseases, management of disease outbreaks, and treatment of immune system related diseases and disorders

Research and development with regard to detecting and diagnosing bacteria in human, veterinary and industrial samples for medical diagnostic purposes in fields that include treatment of infectious diseases, management of disease outbreaks, and treatment of immune system related diseases and disorders; advisory services in the field of technological developments with regard to detecting and diagnosing bacteria in human, veterinary and industrial samples for medical diagnostic purposes in fields that include treatment of infectious diseases, management of disease outbreaks, and treatment of immune system related diseases and disorders; design and development of medical technologies with regard to detecting and diagnosing bacteria in human, veterinary and industrial samples for medical diagnostic purposes in fields that include treatment of infectious diseases, management of disease outbreaks, and treatment of immune system related diseases and disorders; professional advice in the field of technologies aimed at detecting and diagnosing bacteria in human, veterinary and industrial samples for medical diagnostic purposes in fields that include treatment of infectious diseases, management of disease outbreaks, and treatment of immune system related diseases and disorders

Filing History

TOTAL INVALIDATION PROCESSED BY THE IB
Apr 9, 2026 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Mar 26, 2026 INTS
INVALIDATION PROCESSED
Mar 26, 2026 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Sep 30, 2025 INTR
CANCELLED SECTION 71
Jan 31, 2025 C71T
NEW REPRESENTATIVE AT IB RECEIVED
Nov 13, 2020 NREP
NOTIFICATION PROCESSED BY IB
Sep 14, 2018 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Aug 27, 2018 FICS
FINAL DISPOSITION PROCESSED
Aug 27, 2018 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Aug 16, 2018 GPAR
REGISTERED-PRINCIPAL REGISTER
Jul 17, 2018 R.PR
PUBLISHED FOR OPPOSITION
May 1, 2018 PUBO
NOTICE OF PUBLICATION
Apr 11, 2018 NPUB
APPLICATION FILING RECEIPT MAILED
Mar 31, 2018 MAFR
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 28, 2018 CNSA
ASSIGNED TO EXAMINER
Mar 27, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 27, 2018 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Mar 26, 2018 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 22, 2018 REPR